Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $115.2800 (-1.38%) ($115.1000 - $116.7900) on Tue. Nov. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.44% (three month average) | RSI | 51 | Latest Price | $115.2800(-1.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(44%) SPLV(35%) XLP(33%) VYM(31%) DIA(30%) | Factors Impacting ABBV price | ABBV will decline at least -0.72% in a week (0% probabilities). VIXM(-20%) UUP(-12%) IGOV(-4%) VXX(-1%) EDOC(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.72% (StdDev 1.44%) | Hourly BBV | -1.3 () | Intraday Trend | -0.8% | | | |
|
Resistance Level | $116.81 | 5 Day Moving Average | $117.24(-1.67%) | 10 Day Moving Average | $116.89(-1.38%) | 20 Day Moving Average | $116.81(-1.31%) | To recent high | -4.6% | To recent low | 8.3% | Market Cap | $203.387b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |